生存素
脂质体
癌症研究
化学
紫杉醇
寡肽
转移
细胞凋亡
体内
活力测定
药理学
癌细胞
小干扰RNA
转染
阳离子脂质体
癌症
生物
医学
生物化学
内科学
肽
生物技术
基因
作者
Xinyan Chen,Yidi Zhang,Chunming Tang,Chunli Tian,Qiong Sun,Zhigui Su,Lingjing Xue,Yi-Fan Yin,Caoyun Ju,Can Zhang
标识
DOI:10.1016/j.ijpharm.2017.06.071
摘要
The overexpression of survivin in breast cancer cells is an important factor of paclitaxel (PTX) resistance in breast cancer. To overcome PTX resistance and improve the antitumor effect of PTX, we developed a novel liposome-based nanosystem (PTX/siRNA/SS-L), composed of a redox-sensitive cationic oligopeptide lipid (LHSSG2C14) with a proton sponge effect, natural soybean phosphatidylcholine (SPC), and cholesterol for co-delivery of PTX and anti-survivin siRNA, which could specifically downregulate survivin overexpression. PTX/siRNA/SS-L exhibited high encapsulation efficiency and rapid redox-responsive release of both PTX and siRNA. Moreover, in vitro studies on the 4T1 breast cancer cells revealed that PTX/siRNA/SS-L offered significant advantages over other experimental groups, such as higher cellular uptake, successful endolysosomal escape, reduced survivin expression, the lowest cell viability and wound healing rate, as well as the highest apoptosis rate. In particular, in vivo evaluation of 4T1 tumor-bearing mice showed that PTX/siRNA/SS-L had lower toxicity and induced a synergistic inhibitory effect on tumor growth and pulmonary metastasis. Collectively, the collaboration of anti-survivin siRNA and PTX via redox-sensitive oligopeptide liposomes provides a promising strategy for the treatment of breast cancer and metastasis.
科研通智能强力驱动
Strongly Powered by AbleSci AI